India to Kazakhstan: Tobramycin Export Trade Route

The India to Kazakhstan Tobramycin corridor is one of India's established pharmaceutical export routes, with 4 shipments documented worth a combined $86.8K USD. The route is dominated by AVALOR HEALTH CARE PRIVATE LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's tobramycin manufacturing sector.

Across 1 active suppliers, the average shipment value stands at $21.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 73% of all shipments, consistent with tobramycin's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 31 days port-to-port. The route has recorded an annual growth rate of 19.5%, placing it at rank #5 among India's top tobramycin export destinations globally.

On the import side, key buyers of Indian tobramycin in Kazakhstan include TOO ANP, TOO ANP, TOO AVCARE LTD. TOO ANP is the single largest importer with 2 shipments valued at $30.6K USD.

India's tobramycin exports to Kazakhstan are driven primarily by a handful of large-scale manufacturers. AVALOR HEALTH CARE PRIVATE LIMITED with 4 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — buyers in Kazakhstan benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — AVALOR HEALTH CARE PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $21.7K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as tobraxa (tobramycin inhalation solutionusp 300 mg/5 ml) batch no-ba5024, mfg. dt-jan-25, exp. date-dec-26 and tobraxa (tobramycin inhalation solutionusp 300 mg/5 ml) batch no-ba5024 mfg dt-jan-25, exp dt-dec-26, suggesting that buyers in Kazakhstan tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, TOO ANP is the largest importer with 2 shipments worth $30.6K USD — representing 35% of all tobramycin imports from India on this route.